Delivery Order SPE2DB25D7067-SPE2DB25FSVMC
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,365.73 to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 MCG Spray (16GM) on July 22, 2025, with completion scheduled for July 23, 2025. This non-competitive, firm fixed-price delivery order represents a single pharmaceutical supply transaction executed under the company's existing contract vehicle with DLA. The award was placed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a $1,771.10 firm fixed price delivery order to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 MCG Spray in 16GM units, with an ultimate completion date of November 28, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through December 2026. The delivery location is specified as Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,244.88 to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 MCG Spray in 16 GM units. This non-competitive award, issued on September 17, 2025, with an ultimate completion date of September 18, 2025, represents a firm fixed-price delivery order under a larger indefinite delivery contract vehicle. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, which serves as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 micrograms spray (16-gram unit) valued at $1,396.90 under a firm fixed-price contract type. This delivery order, issued on August 19, 2025, represents a non-competitive set-aside and carries an ultimate completion date of August 20, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary...
- The Defense Logistics Agency awarded a delivery order valued at $1,500.54 to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 micrograms spray (16 grams) on June 26, 2025, with completion scheduled for June 27, 2025. This competitively awarded, firm fixed-price contract was issued without set-aside provisions. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery order...
- AmerisourceBergen Drug Corp received a delivery order award from the Defense Logistics Agency (DLA) on September 25, 2025, for Fluticasone Propionate 50 MCG Spray in 16GM units, with a ceiling value of $6,220.80. This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 26, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,158.11 to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 mcg spray (16 gm) on September 4, 2025, with completion scheduled for September 5, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order represents a continuation of AmerisourceBergen's extensive supply...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $1,366.24 by the Defense Logistics Agency (DLA) for the supply of Fluticasone Propionate 50 micrograms nasal spray in 16-gram units. The contract is structured as a firm fixed price delivery order with an ultimate completion date of August 18, 2025, and will be fulfilled from the company's Corporate Office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation applied. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Fluticasone Propionate 50 mcg Spray in 16-gram units, valued at $2,595.26. This non-set-aside, competitively awarded delivery order carries a firm fixed price structure and is scheduled for completion by September 26, 2025. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as a major...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) for Fluticasone Prop 50 MCG Spray 16GM, with a contract value of $2,105.64. The award, issued on September 15, 2025, represents a firm fixed price delivery order with an ultimate completion date of September 16, 2025. The contract involves no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- SPE2DB25D7067Indefinite Delivery Contract
- SPE2DB25D7067-SPE2DB25FSVMCDelivery Order
AmerisourceBergen Drug Corp was awarded a firm fixed-price delivery order by the Defense Logistics Agency (DLA) on August 6, 2025, for Fluticasone Propionate 50 MCG Spray in a 16-gram formulation, valued at $1,045.02. The contract represents a non-set-aside, competitively awarded delivery order with an ultimate completion date of August 7, 2025. Performance will take place at the company's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp's established role as a major federal pharmaceutical distributor and the competitive nature of this award reflect the company's capability to meet Defense Department medical supply requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 8/6/25 |